Anebulo Pharmaceuticals, Inc. (ANEB)
NASDAQ: ANEB · Real-Time Price · USD
1.520
0.00 (0.00%)
Nov 20, 2024, 4:00 PM EST - Market closed
Anebulo Pharmaceuticals Employees
As of June 30, 2024, Anebulo Pharmaceuticals had 3 total employees, including 2 full-time and 1 part-time employees. The number of employees increased by 1 or 50.00% compared to the previous year.
Employees
3
Change (1Y)
1
Growth (1Y)
50.00%
Revenue / Employee
n/a
Profits / Employee
-$2,640,539
Market Cap
39.42M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Jun 30, 2024 | 3 | 1 | 50.00% |
| Jun 30, 2023 | 2 | -2 | -50.00% |
| Jun 30, 2022 | 4 | 1 | 33.33% |
| Jun 30, 2021 | 3 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| BioLineRx | 79 |
| iCAD, Inc. | 69 |
| AN2 Therapeutics | 41 |
| LAVA Therapeutics | 37 |
| CERo Therapeutics Holdings | 9 |
| Nexalin Technology | 6 |
| Lexaria Bioscience | 5 |
ANEB News
- 7 days ago - Anebulo Pharmaceuticals Reports First Quarter Fiscal Year 2025 Financial Results and Recent Updates - Business Wire
- 2 months ago - Anebulo Pharmaceuticals Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Recent Updates - Business Wire
- 4 months ago - Anebulo Pharmaceuticals Awarded NIDA Grant for its Investigational IV Treatment for Acute Cannabis-Induced Toxic Effects - Business Wire
- 6 months ago - Galehead Development to Collaborate With Rivian Automotive on Renewable Energy Project Development - Business Wire
- 6 months ago - Anebulo Pharmaceuticals Reports Third Quarter Fiscal Year 2024 Financial Results and Recent Updates - Business Wire
- 10 months ago - Anebulo Pharmaceuticals Reports Second Quarter Fiscal Year 2024 Financial Results and Recent Updates - Business Wire
- 1 year ago - Anebulo Pharmaceuticals Reports First Quarter Fiscal Year 2024 Financial Results and Recent Updates - Business Wire
- 1 year ago - Anebulo Pharmaceuticals Announces Appointment of Bimal Shah to its Board of Directors - Business Wire